1 / 5
What chart patterns can you find? Look for the following: scallop, diamond, 2 head-and-shoulders, broadening top, high and tight flag.
Answers are on the next slide.
2 / 5
Price after the head-and-shoulders bottom in April has closed above the down-sloping blue neckline.
Question 1: Do you buy, short, or avoid trading this stock?
Question 2: If trading this one, what is the target price?
Question 3: If trading this one, what is the stop price?
General market conditions are on the next slide.
3 / 5
This is a picture of the general market, represented by the S&P 500. I show a descending, broadening wedge, a chart pattern I didn't see when I took the ABGX trade.
I show the green line as when price began forming the left shoulder of the head-and-shoulders bottom in ABGX.
How did the trade go? The 3 questions answered on the next slide.
4 / 5
Question 1: Do you buy, short, or avoid trading this stock? Buy long.
Question 2: If trading this one, what is the target price? 16-17.
Question 3: If trading this one, what is the stop price? 12.94
Here's my notebook entry for the trade.
"4/23/04 I believe price will rise to 16 to 17, and, if lucky, push through to make new highs. Earnings are due a month from today, so that gives us room. Downside is 12.94, stop, for
a loss of 12%.
Filled at: 14.66 to 14.67. Buy/sell reason: Head-and-shoulders bottom upward breakout. Mood: buoyant but rushed. Wanted to get this in before the close and it may be a hip shot.
I'm depending on [the] head-and-shoulders to perform. S&P direction over pattern lifetime: Downward. Future market direction (guess): Hard to tell. I expect market to rise for a few days
until tagging earlier ascending triangle then declining, forming a large double top. Confidence, will trade work? Yes. Confidence is high. Stop: 12.94, or 12%.
Upside target: 16-17.
The next trading day, price shot up as the above chart shows. It blew through my 16-17 target and topped out at 19.50, but closed much lower, at 17.70.
Here's what the Wall Street Journal had to say about the move the next day: "Small companies that are developing cancer treatments saw their shares soar after large-caps Genentech and
OSI Pharmaceuticals reported positive data from a late-stage trial of Tarceva, a lung-cancer treatment."
Question: Do you hold onto the stock for additional gains, sell, or buy more?
The next page shows how I handled it.
5 / 5
Here's my notebook.
Date: 4/27/04. Filled at: 18.308. Sell reason: stock jumped 3 points yesterday on hype. Mood: cautious. I expected the stock to give back almost all of its gains, but it was up
this morning, coming down. A quick decline often follows a quick rise.
As you can see, I sold a day after the stock peaked and made 25%. Not bad for a 3 days of work.
The end.